O.V. CHECHULINA, O.V. DANILOVA

KSMA – Branch Campus of the FSBEI FPE RMACPE MOH Russia, 36 Butlerov Str., Kazan, Russian Federation, 420012

Chechulina O.V. — D. Sc. (medicine), Professor of the Department of Obstetrics and Gynecology, e-mail: chechulina01@gmail.com, ORCID: 0000-0001-9272-9285

Danilova O.V. — Ph. D. (medicine), Associate Professor of the Department of Obstetrics and Gynecology, e-mail: olzaiz@mail.ru, ORCID 0000-0002-6742-0187 To present a personalized approach to choosing a contraceptive method using modern information technologies.

Material and methods. Literature data on the optimal choice of contraception methods were analyzed.

Results. For many women, the side effects that are completely harmless from a doctor’s viewpoint become grounds to reject the benefits of hormonal contraception. This problem can be solved by consulting, adjusting the method if necessary and, in general, choosing the means that are most successful in terms of comfort. It is important for a clinician to convey to the patient that the possible adverse reactions are not dangerous; many of them are only temporary, while others can be overcome by changing the drug. This is the right step towards increasing compliance with hormonal contraception.

Key words: contraception, quality of life of a woman.

(For citation: Chechulina O.V., Danilova O.V. Personalized approach to the choice of contraceptive method. Practical Medicine. 2018)

REFERENCES

1. Isaeva Yu.B. Mediko-sotsialʹnye aspekty kontratseptsii devochek-podrostkov: avtoref. dis. … kand. med. nauk [Medical and social aspects of contraception adolescent girls. Synopsis of dis. PhD med. sciences]. Volgograd, 2008. 27 p.
2. Khamoshina M.B. Reproductive behavior and contraceptive choice of adolescent girls in Primorsky Krai. Akusherstvo i ginekologiya, 2005, no. 2, pp. 46–49.
3. Medical eligibility criteria for contraceptive use. Sth ed. Geneva: WHO, 2015. 267 p.
4. Alesina I.L. Current trends in hormonal contraception. Farmateka, 2011, no, 13. pp. 18-23 (in Russ.).
5. Rossiyskiy statisticheskiy ezhegodnik [Russian statistical yearbook]. Moscow: Rosstat, 2015, available at: http://www.gKs.ru/ bgd/regl/b15_13/Main.htm
6. Konovalov V.A., Kuznetsova I.V. Combined oral contraception as a method of preserving reproductive health. Akusherstvo i ginekologiya, 2014, no.12. pp. 42-47 (in Russ.).
7. Natsionalʹnye meditsinskie kriterii priemlemosti metodov kontratseptsii [National Medical Eligibility Criteria for Contraception]. Moscow, 2012. 21 p.
8. Simonovskaya Kh.Yu., Makletsova S.A. Rethinking indications for estrogen-progestin preparations. StatusPraesens, 2014, no. 6 (23), pp. 49-58 (in Russ.).
9. Klipping C., Duijkers I., Trummer D. et al. Suppression of ovarian activity with drospirenone-containing oral contraceptive in a 24/4 regimen. Contraception, 2008;78:16-25.
10. European Society of Human Reproduction and Embryology. Future reproductive lifespan may be lessened in oral contraceptive users: lower measures of ovarian reserve. ScienceDaily, 2014.
11. Deb S. Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Mullerian hormone and small antral follicle count using three-dimensional ultrasound. Ultrasound. Obstet. Gynecol., 2012, vol. 39, pp. 574-580.
12. Barnhart K.T., Schreiber C.A. Return to fertility following discontinuation of oral contraceptives. Fertil and Steril., 2009, vol. 91, no. 3, pp. 659-663.
13. Havrilesky L.J., Gierisch J.M., Moorman P.G. et al. Oral contraceptive use for the primary prevention of ovarian cancer. Evid. Rep. Technol. Assess (Full Rep), 2013, vol. 212 (1), p. 514.
14. Depozitariy reproduktivnogo zdorovʹya: molodye zhenshchiny. Puti formirovaniya ratsionalʹnykh predposylok k regulyatsii fertiʹnosti. Metodicheskoe rukovodstvo M.B. Khamoshina; pod red. V.E. Radzinskogo [Reproductive health depository: young women. Ways of formation of rational prerequisites for the regulation of fertility. Methodical manual of M.B. Khamoshin. Edit. by V.E. Radzinskiy]. Redaktsiya zhurnala StatusPraesens, 2013.
15. Radzinskiy V.E., Polina M.L. Gestagen IV pokoleniya drospirenon: novoe yavlenie v sovremennoy ginekologii? Klinicheskaya lektsiya [Progestin IV generation Drospirenone: a new phenomenon in modern gynecology? Clinical lecture]. Moscow: Redaktsiya zhurnala StatusPraesens, 2011, 20 p.
16. The Effect of 2 Combined Oral Contraceptives Containing Either Drospirenone or Cyproterone Acetate on Acne and Seborrhea Willem A. van Vloten et al., 2002.
17. Aganezova N.V., Aganezov S.S. Upravlenie menstrualʹnym tsiklom kak zalog komplaentnosti. Informatsionnyy byulletenʹ [Managing the menstrual cycle as a key to compliance. Newsletter]. Moscow: Redaktsiya zhurnala StatusPraesens, 2014. 24 p.
18. Samtsov A.V. Akne i akneformnye dermatozy. Monografiya 2-e izdanie [Acne and acneform dermatosis. Monograph 2nd edition], 2014.
19. Zilʹberberg N.V, Brilʹ Yu.A. Facial skin aging: questions and answers. Status Praesens. Ginekologiya, akusherstvo, besplodnyy brak, 2015, 2(25):112-118 (in Russ.)